The actions of GLP-1 on insulin and glucagon secretion inspired the development of several GLP-1 receptor (GLP-1R) agonists that have revolutionized treatment for obesity and diabetes (12, 13). Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.